ANI Pharmaceuticals, Inc.
ANIP
$82.10
-$0.57-0.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.11% | -9.53% | -34.86% | -31.64% | -20.61% |
| Total Receivables | 28.65% | 35.86% | 27.79% | 36.80% | 9.80% |
| Inventory | -1.06% | 10.26% | 20.71% | 23.01% | 38.89% |
| Prepaid Expenses | 6.23% | 8.09% | 46.83% | 2.16% | 64.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 49.71% | -89.39% | -22.00% | -97.09% | -22.88% |
| Total Current Assets | 33.97% | 8.49% | -0.79% | 1.51% | 4.84% |
|
|
|||||
| Total Current Assets | 33.97% | 8.49% | -0.79% | 1.51% | 4.84% |
| Net Property, Plant & Equipment | 12.09% | 14.73% | 19.89% | 27.52% | 28.32% |
| Long-term Investments | 3.40% | 114.50% | 114.95% | 112.57% | 114.12% |
| Goodwill | 3.40% | 114.50% | 114.95% | 112.57% | 114.12% |
| Total Other Intangibles | -12.29% | 184.21% | 174.68% | 159.24% | 159.21% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.12% | 5.60% | 5.70% | -4.27% | -16.51% |
| Total Assets | 9.38% | 45.86% | 41.32% | 41.94% | 44.66% |
|
|
|||||
| Total Accounts Payable | 14.62% | 12.10% | 7.34% | 24.46% | 78.68% |
| Total Accrued Expenses | 62.14% | 109.28% | 92.38% | 56.93% | 92.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.10% | 1,454.82% | 1,216.82% | 1,218.94% | 741.41% |
| Total Finance Division Other Current Liabilities | 30.55% | 51.02% | 27.34% | -8.09% | -31.48% |
| Total Other Current Liabilities | 30.55% | 51.02% | 27.34% | -8.09% | -31.48% |
| Total Current Liabilities | 42.45% | 69.19% | 47.43% | 33.13% | 41.37% |
|
|
|||||
| Total Current Liabilities | 42.45% | 69.19% | 47.43% | 33.13% | 41.37% |
| Long-Term Debt | -2.13% | 113.91% | 114.90% | 115.90% | 116.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.30% | 43.11% | 38.87% | -- | 32.04% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -62.78% | 166.11% | 155.32% | 154.24% | 292.91% |
| Total Liabilities | 5.34% | 100.25% | 93.95% | 91.39% | 96.82% |
|
|
|||||
| Common Stock & APIC | 14.74% | 1.77% | 1.42% | 1.08% | 0.87% |
| Retained Earnings | 43.54% | -18.20% | -36.38% | -25.14% | -10.78% |
| Treasury Stock & Other | -94.24% | -141.44% | -193.84% | -1,182.35% | -463.37% |
| Total Common Equity | 24.60% | -4.17% | -7.38% | -6.72% | -5.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 24.60% | -4.17% | -7.38% | -6.72% | -5.56% |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.41% | -3.95% | -6.99% | -6.35% | -5.26% |
|
|
|||||